Results 161 to 170 of about 13,727 (197)

Sacubitril/valsartan and quality of life assessed using the EuroQol Five-dimension Three-level questionnaire level sum score (EQ-5D-3L-LSS) in patients with HFrEF and HFmrEF/HFpEF. [PDF]

Eur Heart J Cardiovasc Pharmacother
Yang M, Henderson AD, Anand IS, Desai AS, Lam CSP, Maggioni AP, Martinez FA, Rouleau JL, Swedberg K, Vaduganathan M, van Veldhuisen DJ, Zannad F, Zile MR, Packer M, Rizkala A, Lewis EF, Jhund PS, Solomon SD, McMurray JJV.   +18 more
europepmc   +1 more source

Cardiorenal safety and efficacy of angiotensin receptor-neprilysin inhibitors in heart failure across the ejection fraction spectrum: A meta-analysis and meta-regression of RCTs with 28,001 patients. [PDF]

Biomed Rep
Rampengan DDCH, Surya SC, Tjandra KC, Lele JAJMN, Rampengan SH, Kadariswantiningsih IN, Idrisov B, Idrisova A, Empitu MA.   +8 more
europepmc   +1 more source

Advances in the Pharmacological Treatment of Heart Failure With Preserved Ejection Fraction. [PDF]

Int J Heart Fail
Valente V, Beer BN, Savarese G.
europepmc   +1 more source

Hyperkalemia in Heart Failure with Reduced Ejection Fraction Patients Treated with Sacubitril/Valsartan: Experience from a Tertiary Cardiac Center in Riyadh, Saudi Arabia. [PDF]

Clin Pract
Alyousif SM, Alaqil NK, Abdelshafy M, Alasmari T, Alqadhy NH, Alzahrani NS, Alhefdhi MA, Alqahtani NA, Omair A, Alsaileek A.   +9 more
europepmc   +1 more source

C3 mutation-associated atypical hemolytic uremic syndrome with severe renal dysfunction and hypertensive emergency successfully treated with ravulizumab and sacubitril/valsartan: a case report. [PDF]

BMC Nephrol
Yanagidani H, Maeoka Y, Yoshida M, Ueda M, Kumano M, Takahashi A, Okubo A, Kato N, Maruyama S, Masaki T.   +9 more
europepmc   +1 more source

Impact of Predischarge NT-proBNP on Treatment Optimisation in Acute Heart Failure. [PDF]

Int J Mol Sci
Polovina M, Tomić M, Janković M, Civrić D, Stojićević A, Stanković S, Pejović T, Viduljević M, Krljanac G, Ašanin M, Stanković S, Seferović PM.   +11 more
europepmc   +1 more source

The efficacy and safety of left bundle branch pacing combined with sacubitril/valsartan or enalapril in the treatment of elderly coronary heart disease with chronic heart failure. [PDF]

Pak J Med Sci
Zhao C, Zhang H, Zhang J, Chen K.
europepmc   +1 more source

Beyond circulating cGMP: revisiting compartmentalized signaling in HFrEF. [PDF]

Int J Cardiol Heart Vasc
Pütz R, Herwig M, Delalat S, Sultana I, Akin I, Hamdani N, El-Battrawy I.   +6 more
europepmc   +1 more source

Influence of Daily Salt Intake on Blood Pressure and Atrial Natriuretic Peptide Levels in Patients Treated with Sacubitril/Valsartan. [PDF]

Intern Med
Sato T, Watanabe S, Aizawa Y.
europepmc   +1 more source